January 13, 2021 | Volume III, Issue 1

White Coat Ceremony

LCME Accreditation Enters Final Phase

As 2021 begins, the Larner College of Medicine is entering the “home stretch” of its once-every-eight-year accreditation process by the Liaison Committee on Medical Education (LCME). For over a year, all aspects the College’s medical education have been closely examined by an LCME Task Force and 12 subcommittees comprising nearly 300 members of the Larner community – including faculty, staff, and medical students. This broad group, led by Professor of Medicine and Associate Dean for Public Health and Health Policy Jan Carney, M.D., M.P.H., compiled extensive data and conducted a  “self-study” analysis of the College’s strengths and areas of improvement – the findings of which will be shared with the LCME. 

Due to the ongoing COVID-19 pandemic, the LCME site visit to the College will take place online rather than in-person but will remain scheduled for its original dates of April 11 to 14.

To prepare for the LCME site visit in April, a mock site visit will be held on January 19 and 20. During the mock visit, experienced consultants well-versed in the workings of LCME accreditation will lead selected College faculty, staff, and students through a detailed examination, similar to what will take place in April. The process allows participants to gain experience in presenting information and will be used by the College to identify areas of focus for further work ahead of the official April online site visit.

Image above: LCME Accreditation Update. Text reads “LCME Accreditation Update Key Dates: Virtual Mock Site Visit January 19-20, 2021, Virtual Site Visit, April 11-14, 2021.” 

Photo of the Univeristy of Vermont Medical Center

UVM Medical Center & Vaccine Testing Center Complete COVID-19 Vaccine Trial Enrollment

In just four weeks, the University of Vermont Medical Center and Vaccine Testing Center at the Larner College of Medicine successfully reached and surpassed the target of 250 enrollees for an ongoing Phase 3 clinical trial of the AstraZeneca COVID-19 vaccine.

More than 3,100 people registered to participate in the local vaccine trial, for which enrollment was completed on December 22, 2020. The UVM site was able to enroll nearly 65 percent of volunteers over the age of 65 – a critically important demographic for testing efficacy and safety and a unique, local contribution to the nationwide study. Additionally, more than 12 percent of participants identify as Black, Indigenous or persons of color. The UVM Medical Center site administered 284 individuals with vaccine or placebo, evenly split between men and women.

“We owe a large debt of gratitude to our community volunteers who participated in this important final stage of evaluation of this COVID vaccine with our research team at UVM Medical Center,” said Beth Kirkpatrick, M.D., co-director of the Vaccine Testing Center, chair of microbiology and molecular genetics, and an infectious disease expert at UVM Medical Center. 

Read more about UVM's COVID-19 vaccine trial enrollment completion.

Pictured above: Cassandra Ventrone, a research technician in the Vaccine Testing Center, processes materials for the AstraZeneca COVID-19 vaccine trial. (Photo: Ryan Mercer, UVM Medical Center)

MLK Presentation Newsletter(1)

On Wednesday, January 20, at 5:30 PM the Annual Rev. Dr. Martin Luther King Jr. Celebration at the University of Vermont is presenting a lecture by Leon McDougle, M.D., M.P.H., titled "Slave Health Deficit: The Journey to Health Parity." The event is free and open to the public. Free virtual tickets are required.

Find information and tickets at

Drs. Dauerman, Dixon, Weiss and Botten

Showing Up for Vermont Providers during a Pandemic

In response to Vermont’s first confirmed case of COVID-19 on March 7, 2020, the Vermont Department of Health (VDH) set up an 8 a.m. to 5 p.m. hotline and was quickly inundated with calls from medical professionals and community members alike. Within a span of about 48 hours, physician appointments moved to telehealth, and providers were faced with myriad challenges, including new workflows, new technology, and reimbursement issues. 

A regular partner with VDH, Vermont Child Health Improvement Program representatives, including Executive Director Judy Shaw, Ed.D., M.P.H., R.N., Professor of Pediatrics Wendy Davis, M.D., and Associate Professor of Pediatrics Breena Holmes, M.D., leveraged VCHIP’s CHAMP (Child Health Advances Measured in Practice) program to help share just-in-time and sorely-needed COVID-19 information with the pediatric and family medicine providers in their network and beyond. 

“VCHIP is known for saying ‘how can we help?’” says Dr. Shaw, a professor of pediatrics and nursing who built VCHIP – founded in 1999 – to rapidly respond to the Vermont pediatrics community’s needs.

On March 13, VCHIP and VDH leaders met, and on March 18, they tested their idea to hold the COVID edition of the CHAMP call to push out information, while Department of Health representatives listened. “What transpired was just magical,” Shaw says.

Read the full article on the Larner website.

Pictured above: VCHIP CHAMP network member and North Country Pediatrics Medical Director Alexandra Bannach, M.D. (far right), and her staff at their practice in Newport, Vt. (Courtesy photo)


Cancer Rehab Program Transforms to Meet Survivors Needs During Pandemic

Despite the many challenges presented by the COVID-19 pandemic, the resilience of University of Vermont Cancer Center patients and continued commitment of providers have led to a silver lining: a way to ensure patients in locations throughout Vermont and upstate New York are receiving the physical and mental health support they need right from the comfort of their own homes.

The Cancer Center’s Steps to Wellness Oncology Rehabilitation program, formerly located on Tilley Drive in South Burlington, includes a free, 12-week exercise, nutrition, and education program to support cancer patients during and after treatment. More than 1,000 patients have benefitted from the program, achieving outcomes such as better strength, weight management, and lower rates of depression and anxiety. “Graduates” of the program, who often continue after the 12 weeks, regularly comment on the tremendous benefits of belonging to the group.

Steps to Wellness co-founder Patti O’Brien, M.D., assistant professor of medicine, and Medical Director Kim Dittus, M.D., Ph.D., associate professor of medicine, have long envisioned expanding access to this highly successful, medically informed oncology rehab program they launched nearly a decade ago.  

“Steps to Wellness has become a key part of my being proactive in a quest for health,” says Patricia Johnson, a stage 4 cancer survivor and committed Steps to Wellness participant. Johnson began the program in December 2019 and was able to continue participating through the pandemic, thanks to expansion of the program to a virtual format. “You are not isolated and alone in this journey,” she says. 

Read the full article on the Larner College of Medicine website.

Pictured above: UVM Cancer Center Steps to Wellness exercise trainer Rebecca Reynolds, B.A., CES/CPT, demonstrates an exercise to cancer survivors via Zoom. (Photo: UVM Cancer Center)


Join the Teaching Academy for the annual Induction and Award Ceremony today, Wednesday, January 13, at 4 p.m. Find the Zoom link to the induction and award event on the Teaching Academy website.

Register for the annual Snow Season Education Retreat on Thursday, January 14, here.

Pictured above: Graphic with background photo of snow-covered trees and white text with a dark green background. Text reads “2021 Teaching Academy Snow Season Education Retreat.” 

Accolades & Appointments

Gilman Allen
Gilman Allen, M.D., professor of medicine, completed the examination of special competency in critical care echocardiography from the National Board of Echocardiography.

Sean Diehl
Sean Diehl, Ph.D., associate professor of microbiology and molecular genetics, has been elected a member of the Henry Kunkel Society (HKS), a prestigious organization created in 1990 in honor of the late longtime Rockefeller Institute (now University) scientist, who earned an international reputation for his contributions to the field of basic and clinical immunology, particularly in liver disease, rheumatic diseases and other allied disorders. HKS is dedicated to fostering patient-based and patient-oriented scientific research, particularly in the field of immunology. The Society has more than 400 elected members, all dedicated to experimental medicine in the field of human immunology.

Stephen Higgins

The Society for the Advancement of Behavior Analysis (SABA) has selected Stephen Higgins, Ph.D.,professor of psychiatry and director of the Vermont Center on Behavior and Health , as the recipient of the 2022 SABA Award for Scientific Translation. The award recognizes Dr. Higgins’ use of behavior science principles and methods to address drug use and the intersections of addiction with other maladaptive behaviors and outcomes. SABA said that his “work in the science of drug dependence has made you not only a leader but indeed a standard-bearer in this area.” The award will be presented in May 2022.

Amanda Kennedy
Amanda Kennedy, Pharm.D., BCPS, professor of medicine, served on an Agency for Health Research and Quality study section on “Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 Special Emphasis Panel.”

Rachel McEntee
Rachel McEntee, M.D., assistant professor of medicine, has accepted the position of UVM Medical Center Director of Medical Informatics. Since joining the UVM Health Network Medical Group as a hospitalist in 2015, she has served as a member of the clinical informatics team with an ongoing focus on electronic medical record (EMR) usability. Dr. McEntee is an Epic physician builder and leads the Optimization Sprint. Her other interests include curriculum development and teaching communication and teamwork skills using medical simulation.

Peter Spector
Peter Spector, M.D., professor of medicine, received a $225,000 Small Business Innovation Research Award from the National Science Foundation. He also raised $10,500,000 in Series A funding for development of an ultra-high resolution multi-electrode array catheter and new mapping software that tracks catheter location in 3-D space, builds a 3-D surface of the heart chamber, and projects electrical data onto the surface. The funding covers the project up to the stage of FDA submission. In addition, Dr. Spector and his team have developed novel algorithms for mapping atrial fibrillation, an irregular heartbeat condition that can lead to blood clots, stroke, and heart failure.

Charlotte Teneback
Charlotte Teneback, M.D., associate professor of medicine, was elected to the Protocol Review Committee of the Cystic Fibrosis Foundation Therapeutic Development Network.



Lahey T, DeRenzo EG, Crites J, Fanning J, Huberman BJ, Slosar JP. Building an Organizational Ethics Program on a Clinical Ethics Foundation. Journal of Clinical Ethics 2020; 2020 Fall;31(3):259-267. PMID: 32960808 House SA, Shubkin CD, Lahey T, Brosco JP, Lantos J. COVID-19 Trial Enrollment for Those Who Cannot Consent: Ethical Challenges Posed by a Pandemic. Pediatrics. 2020 Oct 7:e2020010728. doi: 10.1542/peds.2020-010728. PMID: 33028661.

Lahey T. “The Bottom of the Health Care Rationing Iceberg” New England Journal of Medicine December 3, 2020; 383:2200-2201. doi: 10.1056/NEJMp2021953. Epub 2020 Nov 28. PMID: 33252205 

Lahey T, Herbst J. “A Small-Town Heart: Should Clinicians Suspect a Rural Mother of Neglect” Hastings Center Reports 2020 Nov;50(6):4-7. doi: 10.1002/hast.1192. PMID: 33315248

Arce Rentería M, Gillett SR, McClure LA, Wadley VG, Glasser SP, Howard VJ, Kissela BM, Unverzagt FW, Jenny NS, Manly JJ, Cushman M. C-reactive protein and risk of cognitive decline: The REGARDS study. PLoS One. 2020 Dec 31;15(12):e0244612. doi: 10.1371/journal.pone.0244612. PMID: 33382815; PMCID: PMC7774911.

Gupta DK, Marano M, Zweber C, Boyd JT, Kuo SH. Prevalence and Relationship of Rest Tremor and Action Tremor in Parkinson's Disease. Tremor Other Hyperkinet Mov (N Y). 2020 Dec 23;10:58. doi: 10.5334/tohm.552. PMID: 33384882; PMCID: PMC7757606.

Nicoli CD, Plante TB, Long DL, Judd SE, McClure LA, Arora P, Cushman M. N-Terminal Pro-B-Type Natriuretic Peptide and Longitudinal Risk of Hypertension. Am J Hypertens. 2020 Dec 30:hpaa224. doi: 10.1093/ajh/hpaa224. Epub ahead of print. PMID: 33378421.

Wang H, Rosendaal FR, Cushman M, van Hylckama Vlieg A. Procoagulant factor levels and risk of venous thrombosis in the elderly. J Thromb Haemost. 2021 Jan;19(1):186-193. doi: 10.1111/jth.15127. Epub 2020 Dec 22. PMID: 33090602.

Sprague BL, Vacek PM, Mulrow SE, Evans MF, Trentham-Dietz A, Herschorn SD, James TA, Surachaicharn N, Keikhosravi A, Eliceiri KW, Weaver DL, Conklin MW. Collagen Organization in Relation to Ductal Carcinoma In SituPathology and Outcomes. Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):80-88. doi: 10.1158/1055-9965.EPI-20-0889. Epub 2020 Oct 20. PMID: 33082201.

Young LW, Hu Z, Annett RD, Das A, Fuller JF, Higgins RD, Lester BM, Merhar SL, Simon AE, Ounpraseuth S, Smith PB, Crawford MM, Atz AM, Cottrell LE, Czynski AJ, Newman S, Paul DA, Sánchez PJ, Semmens EO, Smith MC, Turley CB, Whalen BL, Poindexter BB, Snowden JN, Devlin LA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT NEONATAL RESEARCH NETWORK AND THE NIH ENVIRONMENTAL INFLUENCES ON CHILD HEALTH OUTCOMES (ECHO) PROGRAM INSTITUTIONAL DEVELOPMENT AWARDS STATES PEDIATRIC CLINICAL TRIALS NETWORK. Site-Level Variation in the Characteristics and Care of Infants With Neonatal Opioid Withdrawal. Pediatrics. 2021 Jan;147(1):e2020008839. doi: 10.1542/peds.2020-008839. Epub 2020 Dec 21. PMID: 33386337; PMCID: PMC7780957.

Andrew AS, Bradley WG, Peipert D, Butt T, Amoako K, Pioro EP, Tandan R, Novak J, Quick A, Pugar KD, Sawlani K, Katirji B, Hayes TA, Cazzolli P, Gui J, Mehta P, Horton DK, Stommel EW. Risk factors for amyotrophic lateral sclerosis: A regional United States case-control study. Muscle Nerve. 2021 Jan;63(1):52-59. doi: 10.1002/mus.27085. Epub 2020 Oct 18. PMID: 33006184.

Cheng LT, Heilbrun ME, Sahani D, Tan BS, Klein JS. COVID-19: preparing for second surge and getting back on track for radiology. BJR Open. 2020 Dec 21;2(1):20200045. doi: 10.1259/bjro.20200045. PMID: 33409448; PMCID: PMC7768396.

Greene SJ, Rosen L. Tracking medical student emotionality in relation to whole body dissection and donation. Clin Anat. 2021 Jan;34(1):128-142. doi: 10.1002/ca.23676. Epub 2020 Sep 23. PMID: 32889750.

Badlam JB, Badesch DB, Austin ED, Benza RL, Chung WK, Farber HW, Feldkircher K, Frost AE, Poms AD, Lutz KA, Pauciulo MW, Yu C, Nichols WC, Elliott CG; USPHSR Investigators. United States Pulmonary Hypertension Scientific Registry: Baseline Characteristics. Chest. 2021 Jan;159(1):311-327. doi: 10.1016/j.chest.2020.07.088. Epub 2020 Aug 26. PMID: 32858008.

Wang H, Fan L, Song M, Liu B, Wu D, Jiang R, Li J, Li A, Banaschewski T, Bokde ALW, Quinlan EB, Desrivières S, Flor H, Grigis A, Garavan H, Chaarani B, Gowland P, Heinz A, Ittermann B, Martinot JL, Martinot MP, Artiges E, Nees F, Orfanos DP, Poustka L, Millenet S, Fröhner JH, Smolka MN, Walter H, Whelan R, Schumann G, Jiang T. Functional Connectivity Predicts Individual Development of Inhibitory Control during Adolescence. Cereb Cortex. 2020 Dec 31:bhaa383. doi: 10.1093/cercor/bhaa383. Epub ahead of print. PMID: 33386409.

Flyer JN, Sleeper LA, Colan SD, Singh MN, Lacro RV. Effect of Losartan or Atenolol on Children and Young Adults With Bicuspid Aortic Valve and Dilated Aorta. Am J Cardiol. 2020 Dec 29:S0002-9149(20)31400-4. doi: 10.1016/j.amjcard.2020.12.050. Epub ahead of print. PMID: 33383013.

Feedback? Contact Us!


View Archive | Subscribe

Published by the Office of Medical Communications
The Larner College of Medicine
at The University of Vermont
Copyright 2021